TransCode Therapeutics

RNAZ

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-15.66M

EBITDA$-16.19M

EBIT$-16.73M

Pre-tax Income$-27.13M

Net Income$-16.75M

Cash Equivalent$3.99M

Total Debt$189.36K

Book Value$1.39M

Book Value Per Share4.04

Return on Equity (ROE)-1130.17%

Return on Assets (ROA)-229.69%

Return on Invested Capital (ROI)-1130.17%

Net Profit Marginundefined

Current Ratio2.56

Quick Ratio2.10

Long-Term Debt / Equity0.00